PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Sclerosing Solutions”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1979

[The surgical treatment cavernous haemangioma of the soft tissues in the orofaciale region (author's transl)].

The experience gathered in therapy of 85 cavernous haemangioma allows to make the following conclusions: -The therapy of canernous haemangioma is very flexible. Localisation, expansion, increasing, aesthetical and functional troubles determine the indication for the therapeutical way. -Cavernous haemangioma must be operated in early infancy. The complete excision is the best method. The conservative control only with the outlook of a spontanremission is unsafe. -Big haemangioma will be treated by a combined treatment (destroying of blood vessels + surgical therapy). After injection of sclerosing solutions it is possible to exstirpate the haemangioma completely. -Extensive plastic and reconstructive operations will be done first after age of twenty years. The use of adjacent flaps shows suitable results.

Adolescent↗
PubMed1979

The short saphenous vein.

If an incompetent short saphenous vein is overlooked during an operation, varicosities invariably recur. A flush saphenopopliteal venous ligation is essential, since it is difficult to eliminate marked valvular insufficiency at this site by injections of a sclerosing solution. The prone position affords excellent exposure of the saphenopopliteal junction. Since the anatomy varies greatly, a flexible approach is desirable. If the anatomy is straightforward and the junction is close to the popliteal space, a transverse skin incision affords excellent exposure and heals well. Although it does not heal as well, a vertical or S-shaped incision is advisable in more complicated instances because it provides better exposure. If all valvular insufficiency is corrected at operation and the patient checked annually so that any new varices can be eliminated by injections, the leg should remain free of varicose veins.

Humans↗
PubMedDate not supplied

[Experimental basis for a new surgical-therapeutic method for duodenal ulcer: gastric mucoslerosis].

On the basis of studies carried out by chronic experiments in dogs the authors noted, by clinical, chemical, radiological and histological methods, that the chemical sclerosis of the gastric mucosa performed with a sterile, fresh hypertonic solution of glucose at 60%, injected in the sub-mucosa, represents an intervention which is:--physiological, since the sclero-distrophy is achieved of the acid-secreting glands and "targeted" intra-gastric vago-sympathic denervation, while the storage function of the stomach is maintained;--feasible, since it can be easily performed from the technical view point, without hemorrhagic, perforative intra-operatory risks or hepato-renal toxicity;--fiable, since it was constantly accompanied by good clinical and functional results. The radiological examination of the barium passage in the stomach, antrum, pylorus and duodenum is normal.

Animals↗
PubMed1979

The pH of sclerosing agents: a determinant of pleural symphysis.

The rate of success in producing pleural symphysis with intrapleural instillation of sclerosing agents has been variable. Differences in the designs of studies probably account for some of the variability, but the reasons for the remainder are not clear. Since a low pH of the pleural fluid is associated with pleural adhesions and loculations, the pH of the commonly used solutions of sclerosing agents was determined, both in their usual concentrations and when diluted with large quantities of exudative pleural fluid. The buffered solution of tetracycline hydrochloride had the most acidic pH (2.0) and showed little change when diluted by pleural fluid. A 0.5 percent solution of sodium hydroxide had the highest pH (13.0). The remainder of the sclerosing solutions showed a range of pH from 4.3 to 8.7. Experimental and clinical experience suggests that tetracycline consistently has the highest rate of success in producing pleural symphysis. It appears that when proper technique is employed, the pH of the solution of the sclerosing agent is an important determinant of the production of pleural symphysis.

Animals↗
PubMedDate not supplied

[Treatment of duodenal ulcer with chemical sclerosis of the gastric mucosa. Preliminary results].

On the basis of experimental studies and of the results obtained, the authors have applied over the last two years, sclerosis of the gastric mucosa with fresh, sterile solution of hypertonic (66%) glucose in 25 patients with duodenal ulcers and cellular and vagal hyperacidity resistant to medical therapy. Mucosclerosis was associated with gastric drainage in 14 patients with duodenal ulcer complicated by stenosis or hemmorhage. Sclerosis of the gastric mucosa is a physiological intervention because it achieves the sclero-atrophy of the acid-secreting glands and vago-sympatic denervation in the gastric territory, while the storage function of the stomach is maintained. It was not followed by extra-gastric disturbances or antro-pyloric distonia. It is easy to perform from the technical viewpoint and has a high degree of fiability, providing constantly satisfactory clinical, functional and metabolic results. Chemical values of basal secretion have decreased in a constant manner but in 9 patients the values of induced acidity showed inconstant decreases. Gastro-antro-pyloro-duodenal transit was good and all operated patients have gained weight. No diarrhea, dumping or peptic recidives were noted.

Adult↗
PubMed1978

Technical aspects of injection sclerotherapy of acute oesophageal variceal haemorrhage as seen by radiography.

Certain aspects of the technique of injection sclerotherapy are illustrated in a series of 15 patients presenting with acute oesophageal variceal haemorrhage due to bilharzial hepatic fibrosis. The results of this form of treatment are shown. The actual process of variceal injection was done under visual fluoroscopic control, using a mixture of 76 per cent Urografin and 5 per cent ethanolamine oleate. The findings showed that: (a) the sclerosant did not reach the gastric varices which could be a possible source of re-bleeding; (b) intravariceally injected material rapidly escaped from the submucosal varices, where it should stay, to the peri-oesophageal veins; (c) sclerosant remaining on the variceal walls was minimal by the time the Sengestaken tube was inflated.

Acute Disease↗
PubMed1979

Sclerotherapy for hydrocoele and epididymal cysts.

A prospective study was carried out on the efficacy of sclerotherapy for the treatment of hydrocoeles and epididymal cysts. Thirty-six hydrocoeles and 13 epididymal cysts were treated and followed up for between 1 and 2 years. Thirty-four hydrocoeles were cured, 1 failed to respond to treatment and 1 recurred after treatment. All 13 epididymal cysts were cured.

Adult↗
PubMed1976

[Sclerosing therapy of esophageal varicosis (author's transl)].

As long-term results of portosystemic shunt operations for decompression of the portal hypertension are unsatisfactory, the author's therapeutic trials are directed increasingly at local treatment of varicosity. One treatment used is esophagoscopic submucosal sclerosing therapy of the esophageal wall for detachment of the varices from the surface. This method proved to be of great value in 420 patients, as the incidence of fatal recurrences of bleeding was only 12% and primary mortality was 15%. Suggested indications for endoscopic mural sclerosing are discussed. Mural sclerosing associated with transhepatic percutaneous esophageal varix sclerosis (following Lunderquist) might improve the results further in some cases.

Adult↗
PubMed2026

Gelified ethanol for percutaneous sclerotherapy of bone lesions: a systematic review of clinical applications and outcomes.

PURPOSE: To systematically review the available evidence on the feasibility, safety, and clinical effectiveness of percutaneous sclerotherapy using radiopaque gelified ethanol (RGE, Discogel®) for bone lesions. METHODS: A systematic search of MEDLINE, Embase, Web of Science, and Cochrane CENTRAL was performed. Primary studies reporting clinical, technical, and safety outcomes following RGE sclerotherapy for bone lesions were included. Data on patient characteristics, lesion type, procedural details, and outcomes were extracted and synthesized descriptively. RESULTS: Six retrospective studies involving 55 patients (mean age 22.2 ± 20.4 years; range 3-65; 26 females) with 56 lesions and 119 procedures were included (mean 2.16 procedures per patient). Aneurysmal bone cysts (80%) and aggressive vertebral hemangiomas (18%) were the main indications. Technical success was reported in 100% of procedures. Pain outcomes were available for 28 patients, with complete resolution in 64.3% (18/28), partial reduction in 32.1% (9/28), and persistence in 3.6% (1/28). Radiological follow-up (50 lesions) demonstrated complete response in 96% and partial response in 4%. No major adverse events were reported according to CIRSE (≥ 4) or CTCAE (≥ 4) criteria. One SIR grade 3 vertebral fracture occurred without confirmed causal association to RGE. Subsequent surgery was required in 3.6% of lesions. CONCLUSION: Although limited to small retrospective series, current evidence suggests that RGE sclerotherapy is a safe and effective minimally invasive option for selected benign bone lesions. Prospective comparative studies with longer follow-up are warranted.

Humans↗
PubMed1975

Drug-induced pseudolupus.

Of fifteen patients with pseudolupus (a syndrome characterised by recurrent fever, myalgia, arthralgia, pleuritis, pulmonary infiltrates, pericarditis, myocarditis, and by mitochondrial antibodies in the absence of nuclear antibodies), all had been treated with "Venocuran", one of a great number of drugs used for venous diseases. This drug, available in twenty countries under various names, contains phenopyrazone, horse-chestnut extract, and cardiac glycosides extracted from various plants. Further studies revealed that up to 90% of long-term users of venocuran acquired mitochondrial antibodies. This was not true for patients with venous diseases being treated with other drugs. About 30% of long-term users of venocuran might experience prodronal symptoms, such as myalgia and arthralgia, while more than 10% could develop the full disease.

Antibodies↗
PubMed1978

Varicose veins: A comparison of surgery and infection/compression sclerotherapy. Five-year follow-up.

A randomised controlled trial was carried out to compare the clinical outcome 5 years after inpatient surgery and outpatient injection/compression sclerotherapy. 91.3% of those originally treated by injection/compression sclerotherapy and 93.9% of those originally treated surgically were seen at follow-up. 40% of patients treated initially by injection/compression sclerotherapy and 24.2% of those treated surgically were given further treatment. The probability of having no further treatment is significantly greater for those treated surgically. The improved outcome after surgery increased with age, being most striking in those aged over 45. The implications of the 5-year follow-up findings for the long-term cost of treatment are discussed.

Adolescent↗